Table 1.
The characteristics of studied population.
| Clinical Data | Schizophrenia (n = 40) | Healthy Controls (n = 40) | SZ vs. HC | ||
|---|---|---|---|---|---|
| Mean (Median) | SD | Mean (Median) | SD | ||
| Age | 31 (30) | 7.32 | 29 (27) | 7.93 | NS |
| BMI (kg/m2) | 26.6 (26.6) | 5.12 | 24.6 (24.2) | 4.39 | NS |
| Duration of illness (months) | 90 (78) | 83.43 | NA | NA | NA |
| Number of hospitalization | 2.7 (2) | 2.25 | NA | NA | NA |
| Olanzapine equivalents | 18.12 (15) | 13.93 | NA | NA | NA |
| PANSS total | 55.35 (54) | 26.71 | NA | NA | NA |
PANSS—Positive and Negative Symptom Scale; SZ—schizophrenia; HC—healthy control; BMI—body mass index; SD—standard deviation; NA—not applicable; NS—not significant. The Mann–Whitney U-test was used.